Transformative Biotech Purchases Direct-to-PCR Technologies From Summit Biolabs
Market-proven technologies in this intellectual property transaction offers many advantages over traditional PCR testing. BOULDER, Colo., May 18,...
Formation of Transformative Biotech, LLC
Transformative Biotech created to deploy direct-to-PCR technologies in the fields of molecular diagnostics of infectious diseases and...
Summit Biolabs Passes Next COVID-19 Testing Milestone.
AURORA, Colo., Jan. 31, 2022 -- Summit Biolabs, a commercial-stage molecular diagnostics company harnessing the power of direct-to-PCR...
Summit Biolabs Passes Significant Milestones
Summit Biolabs Passes Significant Milestones Dear Investors & Friends of Summit Biolabs: We are pleased to announce that Summit...
Summit Biolabs Announces Certification of Compliance to Perform Testing under CLIA
Aurora, Colorado, June 25, 2021 - - Summit Biolabs, a commercial stage molecular diagnostics companypioneering saliva liquid-biopsy...
Summit Receives Investment from U. of Colorado Anschutz Medical Campus CDI Fund
University of Colorado Anschutz Medical Campus, Chancellor Discovery Innovation Fund (CDI Fund) Finalizes Investment in Summit Biolabs AURORA,...
